Jia Wu1, Micheal F Gensheimer1, Nasha Zhang2, Fei Han3, Rachel Liang1, Yushen Qian1, Carrie Zhang1, Nancy Fischbein4, Erqi L Pollom1, Beth Beadle1, Quynh-Thu Le1, Ruijiang Li5. 1. Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California. 2. Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California; Department of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Jinan, Shandong, China. 3. Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China. 4. Department of Radiology, Stanford University School of Medicine, Stanford, California. 5. Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California. Electronic address: rli2@stanford.edu.
Abstract
PURPOSE: Prognostic biomarkers of disease relapse are needed for risk-adaptive therapy of oropharyngeal cancer (OPC). This work aims to identify an imaging signature to predict distant metastasis in OPC. METHODS AND MATERIALS: This single-institution retrospective study included 140 patients treated with definitive concurrent chemoradiotherapy, for whom both pre- and midtreatment contrast-enhanced computed tomography (CT) scans were available. Patients were divided into separate training and testing cohorts. Forty-five quantitative image features were extracted to characterize tumor and involved lymph nodes at both time points. By incorporating both imaging and clinicopathological features, a random survival forest (RSF) model was built to predict distant metastasis-free survival (DMFS). The model was optimized via repeated cross-validation in the training cohort and then independently validated in the testing cohort. RESULTS: The most important features for predicting DMFS were the maximum distance among nodes, maximum distance between tumor and nodes at mid-treatment, and pretreatment tumor sphericity. In the testing cohort, the RSF model achieved good discriminability for DMFS (C-index = 0.73, P = .008), and further divided patients into 2 risk groups with different 2-year DMFS rates: 96.7% versus 67.6%. Similar trends were observed for patients with p16+ tumors and smoking ≤10 pack-years. The RSF model based on pretreatment CT features alone achieved lower performance (concordance index = 0.68, P = .03). CONCLUSIONS: Integrating tumor and nodal imaging characteristics at baseline and mid-treatment CT allows prediction of distant metastasis in OPC. The proposed imaging signature requires prospective validation and, if successful, may help identify high-risk human papillomavirus-positive patients who should not be considered for deintensification therapy.
PURPOSE: Prognostic biomarkers of disease relapse are needed for risk-adaptive therapy of oropharyngeal cancer (OPC). This work aims to identify an imaging signature to predict distant metastasis in OPC. METHODS AND MATERIALS: This single-institution retrospective study included 140 patients treated with definitive concurrent chemoradiotherapy, for whom both pre- and midtreatment contrast-enhanced computed tomography (CT) scans were available. Patients were divided into separate training and testing cohorts. Forty-five quantitative image features were extracted to characterize tumor and involved lymph nodes at both time points. By incorporating both imaging and clinicopathological features, a random survival forest (RSF) model was built to predict distant metastasis-free survival (DMFS). The model was optimized via repeated cross-validation in the training cohort and then independently validated in the testing cohort. RESULTS: The most important features for predicting DMFS were the maximum distance among nodes, maximum distance between tumor and nodes at mid-treatment, and pretreatment tumor sphericity. In the testing cohort, the RSF model achieved good discriminability for DMFS (C-index = 0.73, P = .008), and further divided patients into 2 risk groups with different 2-year DMFS rates: 96.7% versus 67.6%. Similar trends were observed for patients with p16+ tumors and smoking ≤10 pack-years. The RSF model based on pretreatment CT features alone achieved lower performance (concordance index = 0.68, P = .03). CONCLUSIONS: Integrating tumor and nodal imaging characteristics at baseline and mid-treatment CT allows prediction of distant metastasis in OPC. The proposed imaging signature requires prospective validation and, if successful, may help identify high-risk humanpapillomavirus-positivepatients who should not be considered for deintensification therapy.
Authors: K Kian Ang; Jonathan Harris; Richard Wheeler; Randal Weber; David I Rosenthal; Phuc Felix Nguyen-Tân; William H Westra; Christine H Chung; Richard C Jordan; Charles Lu; Harold Kim; Rita Axelrod; C Craig Silverman; Kevin P Redmond; Maura L Gillison Journal: N Engl J Med Date: 2010-06-07 Impact factor: 91.245
Authors: Brian O'Sullivan; Shao Hui Huang; Jie Su; Adam S Garden; Erich M Sturgis; Kristina Dahlstrom; Nancy Lee; Nadeem Riaz; Xin Pei; Shlomo A Koyfman; David Adelstein; Brian B Burkey; Jeppe Friborg; Claus A Kristensen; Anita B Gothelf; Frank Hoebers; Bernd Kremer; Ernst-Jan Speel; Daniel W Bowles; David Raben; Sana D Karam; Eugene Yu; Wei Xu Journal: Lancet Oncol Date: 2016-02-27 Impact factor: 41.316
Authors: Brian O'Sullivan; Shao Hui Huang; Lillian L Siu; John Waldron; Helen Zhao; Bayardo Perez-Ordonez; Ilan Weinreb; John Kim; Jolie Ringash; Andrew Bayley; Laura A Dawson; Andrew Hope; John Cho; Jonathan Irish; Ralph Gilbert; Patrick Gullane; Angela Hui; Fei-Fei Liu; Eric Chen; Wei Xu Journal: J Clin Oncol Date: 2013-01-07 Impact factor: 44.544
Authors: Stefan Leger; Alex Zwanenburg; Karoline Pilz; Sebastian Zschaeck; Klaus Zöphel; Jörg Kotzerke; Andreas Schreiber; Daniel Zips; Mechthild Krause; Michael Baumann; Esther G C Troost; Christian Richter; Steffen Löck Journal: Radiother Oncol Date: 2018-08-04 Impact factor: 6.280
Authors: Ralph T H Leijenaar; Sara Carvalho; Frank J P Hoebers; Hugo J W L Aerts; Wouter J C van Elmpt; Shao Hui Huang; Biu Chan; John N Waldron; Brian O'sullivan; Philippe Lambin Journal: Acta Oncol Date: 2015-08-12 Impact factor: 4.089
Authors: Tian-Tian Zhai; Lisanne V van Dijk; Bao-Tian Huang; Zhi-Xiong Lin; Cássia O Ribeiro; Charlotte L Brouwer; Sjoukje F Oosting; Gyorgy B Halmos; Max J H Witjes; Johannes A Langendijk; Roel J H M Steenbakkers; Nanna M Sijtsema Journal: Radiother Oncol Date: 2017-07-29 Impact factor: 6.280
Authors: Bhishamjit S Chera; Robert J Amdur; Joel Tepper; Bahjat Qaqish; Rebecca Green; Shannon L Aumer; Neil Hayes; Jared Weiss; Juneko Grilley-Olson; Adam Zanation; Trevor Hackman; William Funkhouser; Nathan Sheets; Mark Weissler; William Mendenhall Journal: Int J Radiat Oncol Biol Phys Date: 2015-08-22 Impact factor: 7.038
Authors: Jia Wu; Xuejie Li; Xiaodong Teng; Daniel L Rubin; Sandy Napel; Bruce L Daniel; Ruijiang Li Journal: Breast Cancer Res Date: 2018-09-03 Impact factor: 6.466
Authors: Hugo J W L Aerts; Emmanuel Rios Velazquez; Ralph T H Leijenaar; Chintan Parmar; Patrick Grossmann; Sara Carvalho; Sara Cavalho; Johan Bussink; René Monshouwer; Benjamin Haibe-Kains; Derek Rietveld; Frank Hoebers; Michelle M Rietbergen; C René Leemans; Andre Dekker; John Quackenbush; Robert J Gillies; Philippe Lambin Journal: Nat Commun Date: 2014-06-03 Impact factor: 14.919
Authors: Chintan Parmar; Ralph T H Leijenaar; Patrick Grossmann; Emmanuel Rios Velazquez; Johan Bussink; Derek Rietveld; Michelle M Rietbergen; Benjamin Haibe-Kains; Philippe Lambin; Hugo J W L Aerts Journal: Sci Rep Date: 2015-06-05 Impact factor: 4.379
Authors: Karen Drukker; Alexandra Edwards; Christopher Doyle; John Papaioannou; Kirti Kulkarni; Maryellen L Giger Journal: J Med Imaging (Bellingham) Date: 2019-09-30
Authors: Rachel B Ger; Shouhao Zhou; Baher Elgohari; Hesham Elhalawani; Dennis M Mackin; Joseph G Meier; Callistus M Nguyen; Brian M Anderson; Casey Gay; Jing Ning; Clifton D Fuller; Heng Li; Rebecca M Howell; Rick R Layman; Osama Mawlawi; R Jason Stafford; Hugo Aerts; Laurence E Court Journal: PLoS One Date: 2019-09-19 Impact factor: 3.240
Authors: Melissa M Chen; Admir Terzic; Anton S Becker; Jason M Johnson; Carol C Wu; Max Wintermark; Christoph Wald; Jia Wu Journal: Eur J Radiol Open Date: 2022-09-29
Authors: Andrew Wentzel; Timothy Luciani; Lisanne V van Dijk; Nicolette Taku; Baher Elgohari; Abdallah S R Mohamed; Guadalupe Canahuate; Clifton D Fuller; David M Vock; G Elisabeta Marai Journal: Radiother Oncol Date: 2021-06-11 Impact factor: 6.901